| [1] |
李朋,赵赋,刘丕楠.神经纤维瘤病的治疗进展[J].中华神经外科杂志, 2015, 31(4): 430-432.
|
| [2] |
Vranceanu AM, Merker VL, Park ER, et al. Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature[J]. J Neurooncol, 2015, 122(2): 219-228.
|
| [3] |
Cohen JS, Levy HP, Sloan J, et al. Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life[J]. Clin Genet, 2015, 88(5): 425-430.
|
| [4] |
Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. 3-dimensional proportional system: an approach to cerebral imaging[M]. New York: Thieme Medical Publishers, 1988.
|
| [5] |
Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain[J]. Neuroimage, 2002, 15(1): 273-289.
|
| [6] |
Acosta MT. Challenges of cognitive research in neurofibromatosis type 1[J]. Lancet Neurol, 2013, 12(11): 1040-1041.
|
| [7] |
North K, Hyman S, Barton B. Cognitive deficits in neurofibromatosis 1[J]. J Child Neurol, 2002, 17(8): 605-612; discussion 627-629, 646-651.
|
| [8] |
Hyman SL, Shores A, North KN. The nature of frequency of cognitive deficits in children with neurofibromatosis type 1[J]. Neurology, 2005, 65(7): 1037-1044.
|
| [9] |
Plasschaert E, Descheemaeker MJ, Van Eylen L, et al. Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1[J]. Am J Med Genet B Neuropsychiatr Genet, 2015, 168B(1): 72-80.
|
| [10] |
Orraca-Castillo M, Estévez-pérez N, Reigosa-Crespo V. Neurocognitive profiles of learning disabled children with neurofibromatosis type 1[J]. Front Hum Neurosci, 2014, 8: 386.
|
| [11] |
Costa Dde S, de Paula JJ, de Rezende NA, et al. Neuropsychological impairments in elderly neurofibromatosis type 1 patients[J]. Eur J Med Genet, 2014, 57(5): 216-219.
|
| [12] |
Pride NA, Crawford H, Payne JM, et al. Social functioning in adults with neurofibromatosis type 1[J]. Res Dev Disabil, 2013, 34(10): 3393-3399.
|
| [13] |
Shilyansky C, Karlsgodt KH, Cummings DM, et al. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance[J]. Proc Natl Acad Sci USA, 2010, 107(29): 13141-13146.
|
| [14] |
Shilyansky C, Lee YS, Silva AJ. Molecular and cellular mechanisms of learning disabilities: a focus on NF1[J]. Annu Rev Neurosci, 2010, 33: 221-243.
|
| [15] |
Violante IR, Ribeiro MJ, Cunha G, et al. Abnormal brain activation in neurofibromatosis type 1: a link between visual processing and the default mode network[J]. PLoS One, 2012, 7(6): e38785.
|
| [16] |
Ferraz-Filho JR, da Rocha AJ, Muniz MP, et al. Diffusion tensor mr imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities[J]. Pediatr Radiol, 2012, 42(4): 449-454.
|
| [17] |
Loitfelder M, Huijbregts SC, Veer IM, et al. Functional connectivity changes and executive and social problems in neurofibromatosis type I[J]. Brain Connect, 2015, 5(5): 312-320.
|
| [18] |
Pride NA, Korgaonkar MS, Barton B, et al. The genetic and neuroanatomical basis of social dysfunction: lessons from neurofibromatosis type 1[J]. Hum Brain Mapp, 2014, 35(5): 2372-2382.
|
| [19] |
Pride N, Payne JM, Webster R. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1[J]. J Child Neurol, 2010, 25(7): 834-841.
|
| [20] |
Buchert R, Von Borczyskowski D, Wilke F, et al. Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1[J]. Nucl Med Commun, 2008, 29(1): 17-26.
|
| [21] |
Apostolova I, Derlin T, Salamon J, et al. Cerebral glucose metabolism in adults with neurofibromatosis type 1[J]. Brain Res, 2015, 1625: 97-101.
|
| [22] |
Schütze M, de Souza Costa D, de Paula JJ, et al. Use of machine learning to predict cognitive performance based on brain metabolism in neurofibromatosis type 1[J]. PLoS One, 2018, 13(9): e0203520.
|